Setting a new standard for the treatment of chronic inflammation. Press Releases Catch up on the latest news from Evommune. November 18, 2020 Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases 123 We have a range of chronic inflammatory disease programs currently in development. See Our Pipeline
